Water Island Capital’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Water Island Capital’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,255,878	Closed	-$26.3M	–	181
2016 Q3	$26.3M	Buy	+1,255,878	New	+$14.5M	1.67%	20

Water Island Capital's VTAE Position: Q4 2016 in Review

Water Island Capital sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 1,255,878 shares — an estimated $26.3M sold.

Water Island Capital first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $26.3M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Water Island Capital reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Water Island Capital sold 1,255,878 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $26.3M.
Water Island Capital first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Water Island Capital's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $26.3M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Water Island Capital's 13F filing for Q4 2016, filed 14 Feb 2017.